Evolent Health (EVH) appointed Dr. Von Nguyen as Chief Medical Officer, effective January 1, 2025. Nguyen joined Evolent as Chief Clinical Officer in July 2024 after serving as clinical lead for population health at Google. Among other previous roles, he has been Chief Medical Officer at Blue Cross North Carolina, Deputy Associate Director of Policy and Strategy at the Centers for Disease Control and Prevention, and Senior Advisor at the Centers for Medicare and Medicaid Services. Nguyen will succeed Dr. Andrew Hertler, who will move to a part-time role as senior advisor and CMO emeritus after more than a decade at Evolent. Hertler will focus on advancing innovation for Evolent’s oncology management solution.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EVH:
- Evolent Health price target lowered to $15 from $45 at JPMorgan
- Evolent Health price target lowered to $28 from $34 at Oppenheimer
- Evolent Health management to meet with Oppenheimer
- Evolent Health price target lowered to $21 from $33 at Citi
- Evolent Health price target lowered to $19 from $39 at Barclays
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
